Settings8H · net · $10k
LanguageThe language of the site
ThemeDark, or a soft blue-grey
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG197.68−0.0094get 0.0012% / 1h26m 23s$51K$82K—Long AZverse
SHORT197.47−0.0260pay 0.0260% / 8h26m 23s$902$118K10xShort GRVT
Price gap−0.105%61s
Funding gap−0.0166% /8h

Both sides work against this direction now: funding costs $5 a day on $10k and the gap is 0.105% under zero (no 7-day history yet). Swap the legs.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding—−0.0166% /8h now · no funding history yet
Price—spread −0.105%61s now · prices read too far apart to compare
Costsno datano order book for AZverse
Result, before costs—+ Points / potential airdropGRVT: points · farm boardneeds funding history

Price and funding

1h · history
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now−0.105%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

MRNA on 27 exchanges

lowest funding first

Before you open

2 ok · 3 to watch
  • Note: Order book unknown—
    No order-book sample for AZverse: its slippage is not counted.
  • Note: Margin at max leverage— + $1,000
    AZverse —, GRVT 10x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • Watch: Payment intervals differ1h / 8h
    Payments land at different times. Close right after the slower leg pays.
    Next 24h at the current rates, on $10k a leg: −$4.98Long AZverse: 24 payments, +$2.82; short GRVT: 3 payments, −$7.80.
  • Watch: Prices read 61 s apart−0.105% vs —
    Part of this gap may be the market moving.
  • Watch: Short leg is thinner$902 vs $51K OI
    GRVT sets your exit cost. Check its book before closing.
  • OK: Points on a legGRVT points
    Volume here counts toward the points program.
  • OK: No KYC on either legAZverse No · GRVT No
    Both exchanges let you trade without ID.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earnedno history yet: current rate−$34.89
Price spreadprices read too far apart to compare—
Slippage, 4 ordersno data for AZverse—
Fee AZverse bp × 2 orders−$12.00
Fee GRVT bp × 2 orders−$9.00
Net, fees only · 7 days · $10k−$55.89
price spread not counted: prices read too far apart
Costs to cover0.210%Break-evennever at this rate
Slippage: AZverse: no order-book sample; GRVT: live order book, 40 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGAZverse—————
SELL · SHORTGRVT2.2832.6 bp−$33doesn’t fitdoesn’t fitdoesn’t fit

Closing costs about the same again.
AZverse: no data.

Alert

MRNA news

posts that mention MRNA, from every exchangeSearch all news →
10-25 09:09AZverseListingnew market mrna_usdt ($MRNA) seen by our collector
10-22 20:48ArcusOther$MRNA fell 25% today and was halted intraday on its primary exchange. The MRNA perp on Arcus kept trading through the halt. Traders could open, reduce, or close positions the entire time - as there is no halt state on Arcus perps. Markets run 24/7. Read more about Arcus RWA Perps here: @arcus_xyz on X ↗
10-22 19:35PhoenixOtherModerna falls after reported leak of Phase 3 melanoma vaccine data showing a 42% cut in recurrence risk, below Phase 2's 49%. $MRNA is trading at $195 on Phoenix, 24/7. @PhoenixTrade on X ↗
10-22 19:27BitgetOtherStay on top of fast-moving stock markets with Bitget Stock Perps. 📈📉 Here's the latest on Moderna $MRNA today ⤵️ @bitget on X ↗
10-20 17:07PhoenixOtherJUST IN: Moderna $MRNA is still climbing, up nearly 7% in the last 24 hours ahead of Saturday's Phase 3 cancer vaccine data at ESMO. @PhoenixTrade on X ↗
10-19 13:46PhoenixOtherJUST IN: $MRNA jumps 8.45% in anticipation of their Stage 3 cancer vaccine clinical trial results releasing on October 24. @PhoenixTrade on X ↗